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Experiences with and attitudes toward car-
rier testing and prenatal diagnosis were eval-
uated among 549 potential and obligate car-
riers of hemophilia. Almost everybody
considered carrier testing to be useful. Forty-
nine percent had been tested for carriership,
10% had only received limited Information,
and 41% had not been tested and had never
received Information about the heredity of he-
mophilia. More married women, women with
severe hemophilia in their family, and women
closely related to a patient with hemophilia
had been tested for carriership than others.
Lack of Information about the probability of
carriership for female relatives and a similar
ignorance of the possibility of carrier testing
were important reasons for not having been
tested. Eleven percent of the women with one
or more children had undergone prenatal di-
agnosis in the past. Thirty-one percent of the
study population would favour prenatal diag-
nosis with the implication of a potential abor-
tion in early pregnancy and half of them
would choose this Option even in late preg-
nancy. Most of the women who objected to
prenatal diagnosis did so because they did not
consider hemophilia to be a sufficiently se-
rious disorder to justify an abortion.
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INTRODUCTION
Improvements in the treatment of hemophilia over
the past 20 years have changed the life of hemophiliacs
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considerably. Hemorrhages are treated with concen-
trated blood products and home treatment and pro-
phylactic treatment have been introduced. As a conse-
quence life expectancy has increased to 66 years and
future generations are expected to suffer less disability
[Smit et al., 1989; Rosendaal et al., 1989]. However, for
many patients hemophilia is still a serious disease be-
cause of arthropathy and complications of treatment
like viral infections (hepatitis, human immunodefi-
ciency virus) and Inhibitor development. Seventeen per-
cent of Dutch hemophiliacs became HlV-seropositive in
the years prior to 1985 IRosendaal et al., 1988]. In 1985,
donors belonging to a risk group for AIDS were re-
quested to withdraw. Furthermore, screening of blood
donations and heat treatment of blood products were
introduced in 1985. These measures substantially re-
duced the risk of infection.
During the same period, developments in clinical ge-
netics have offered the female relatives of hemophiliacs
the opportunity of attaining more certainty about their
progeny. In the Seventies a more reliable method based
on pedigree analysis and clotting factor VIII or IX assays
became available by which 70 to 80% of potential car-
riers could be informed of a probability of carriership
lower than 5% or higher than 95% [Akhmeteli et al.,
1977; Green et al., 1986]. In 1984 it became possible to
ascertain the carrier status by means of DNA analysis
[Giannelli et al., 1984; Harper et al., 1984; Bröcker-
Vriends et al., 1985, 1987]. At present restriction frag-
ment length polymorphism analysis is informative for
most of the potential carriers. In combination with coag-
ulation assays, DNA analysis now offers more certainty
to more of the women at risk [Bröcker-Vriends et al.,
1987].
Prenatal diagnosis for hemophilia has been available
since 1970 and was at first restricted to amniocentesis in
the 16-18th gestational week to determine the sex of
the fetus. In 1979 it became possible to sample fetal
blood and to measure fetal clotting factors. This pro-
cedure can only be performed in the 18—20th week of
pregnancy in specialized centers. Since 1985 prenatal
diagnosis in the 8-10th week has become possible by
chromosome analysis and, if the fetus appears to be
male, DNA analysis of chorion villi [Bröcker-Vriends et
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al., 1988] is available. Prenatal diagnosis in the first
trimester of pregnancy implies a shorter period of uncer-
tainty for the couple. Also, termination of pregnancy in
the case of an affected fetus may be physically and emo-
tionally less demanding at this stage.
Several studies have been conducted on the experi-
ence of female relatives of hemophiliacs with genetic
counseling, carrier testing or prenatal diagnosis [Mark-
ova et al., 1984,1986; Evans and Shaw, 1979; Barrow et
al., 1982; Miller et al., 1987; Kraus and Brettler, 1988;
Ljung et al., 1987; Beeson and Golbus, 1985; Prancis and
Kasper, 1983; Lubs and Falk, 1977]. Most of these
studies focused on reproductive behaviour and attitudes
toward prenatal diagnosis. They show varying results
regarding attitudes toward prenatal diagnosis, al-
though generally the majority of respondents were op-
posed to it. Lubs and Falk [1977], in addition, examined
the use of genetic counseling and carrier testing. They
contacted the female relatives of hemophiliacs through
patients and patients' associations and found that less
than half of the female relatives had received genetic
counseling, with the exception of mothers of patients. A
disadvantage of many of the above-mentioned studies is
that they have been conducted on women who were
registered at hemophilia treatment centers [Markova et
al., 1984, 1986; Evans and Shaw, 1979; Barrow et al.,
1982; Miller et al., 1987; Kraus and Brettler, 1988], a
coagulation laboratory [Ljung et al., 1987], or a depart-
ment of obstetrics [Beeson and Golbus, 1985]. The sam-
ples in these studies were often small and the fact that
many of the respondents in these studies were mothers
of a hemophilic son implies a bias.
In our article results will be presented on a survey
among a large group of female relatives of hemophiliacs
in The Netherlands. These potential and obligate car-
riers were contacted through patients. The aim of the
study was to assess knowledge of, attitudes toward, and
the use of carrier testing and prenatal diagnosis. We
also assessed the influence on these parameters of mari-
tal status, parenthood, severity of hemophilia in the
family, and family relation to the nearest patient in the
family.
PATIENTS AND METHODS
Subjects
The number of hemophilia patients in The Nether-
lands is estimated to be between 1,200 and 1,300 [Rosen-
daal et al., 1989]. Eleven hundred and sixty-two regis-
tered patients were requested to supply us with the
addresses of their mothers, daughters, sisters, and ma-
ternal aunts. Half of the patients sent us the addresses of
some or all of these female relatives. Eider sisters and
aunts were asked to give us the addresses of their daugh-
ters. In this way we acquired a list of addresses of
mothers, sisters, daughters, aunts, cousins, and nieces.
Women in the age group from 18 to 38 years were se-
lected in order to include most of the women for whom
carrier testing and prenatal diagnosis may be relevant
or may have been relevant in recent years. In 1987, the
women selected (n = 654) were sent a letter of introduc-
tion which explained the purpose of the survey. Two
weeks later they received a standardized mail question-
naire. This procedure was approved by the Medical
Ethics Committee of the University Hospital, Leiden.
At the time of the survey we also performed another
study among 114 possible carriers of hemophilia. The
purpose of that study was to evaluate the contents and
effects of genetic counseling and carrier testing given at
the University Hospital of Leiden. Thirty-one of these
114 women were also on the list of addresses we gath-
ered via the hemophiliacs. For reasons of represen-
tativeness, the data on these 31 women have been in-
cluded in this study. This was possible because the
studies were to a large extent overlapping. However,
some detailed questions were not asked to these 31 wo-
men.
Five hundred and seventy-nine questionnaires were
returned. Thirty were excluded from analysis because
the respondents did not meet the age-limit criterion
(14), questionnaires were not filled in (4) or not com-
pleted (9), or for other reasons (3). Disregarding the
respondents who were too young or too old, the response
rate was 86%.
Two methods were used to estimate how many of the
female relatives of hemophiliacs in The Netherlands
participated. The evaluative study mentioned above
comprised 97 women in the age group 18 to 38 years. If
we had reached 100% of the potential and obligate car-
riers in The Netherlands, these 97 women would have
been listed in our file of addresses. The overlap was 31
addresses which means that, at most, one third of all
potential and obligate carriers were on our mailing list.
The other method is based on a demographic assump-
tion on the number of female relatives of hemophiliacs.
Here we restrict ourselves to one subgroup of female
relatives, the sisters, and take the group of hemophiliacs
aged 18-38 years äs a starting point. Four hundred and
twenty-eight hemophiliacs in this age group partici-
pated in a Dutch survey that was estimated to cover
± 75 percent of the Dutch hemophiliacs [Rosendaal et
al., 1989]. Thus, there were ± 571 hemophiliacs aged
18-38 years in The Netherlands. Based on the assump-
tion of 1.5 sisters in a sibship for this age-group (Central
Bureau of Statistics, Department of Population Statis-
tics, unpublished figure), the number of sisters aged
18-38 years was expected to be ± 857. In our survey 235
sisters participated which means that ± 27 percent of
this subgroup was covered. Assuming a coverage that is
about the same for the other subgroups, we estimated
that about a quarter of the total group of potential and
obligate carriers was covered by our survey.
Concepts and Measurement Instruments
It is important to distinguish between the concepts of
genetic counseling, Information about hereditary dis-
eases, and carrier testing. Methodological considera-
tions dissuaded us from paying attention to the question
of whether or not the respondents had received genetic
counseling; neither did we try to evaluate genetic coun-
seling äs provided to the respondent. Genetic counseling
has developed over the past decades from an incidental
activity of physicians to a medical specialty with spe-
cified subject matters, procedures, and objectives. Given
this Professional development, and given the way we
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contacted female relatives, through patients and not
through departments of clinical genetics or hemophilia
centers, answers on the question of whether or not ge-
netic counseling was received were considered difficult
to Interpret. The respondents were classified into three
groups: 1) women who had been tested for carriership, 2)
women who had not been tested, but who were informed
by a physician about the heredity of hemophilia, and 3)
women who had not been tested and who never were
informed about the heredity of hemophilia.
Many respondents were related to more than one pa-
tient. To establish the family relation to the nearest
patient we employed the following order of proximity:
mother, sister, daughter, aunt, niece (daughter of sister),
and cousin (daughter of aunt).
Twenty-three Statements were phrased about hemo-
philia, the heredity of hemophilia, and about the pres-
ent facilities of carrier testing and prenatal diagnosis, to
test the knowledge of the respondents. They were asked
whether they agreed or disagreed with the Statements,
half of which were formulated incorrectly. For every
right answer a score of l was assigned, after which the
total score was calculated.
The respondents were asked whether or not they con-
sidered a termination of pregnancy acceptable in a se-
ries of different circumstances. The answers were an-
alysed by Mokken scale analysis [Mokken, 1971], the
purpose of which was to analyse whether it was possible
to arrange the circumstances from more to less accept-
able; this means that a positive answer for a "less accept-
able" circumstance implies a positive answer for a "more
acceptable" circumstance. The scalability coefficient H
was .54, which means that the items, äs formulated in
Table VIII, form a "strong" hierarchical scale; the re-
Hability coefficient r was .77.
RESULTS
General Characteristics
Table I shows the general characteristics of the sur-
veyed population. The distribution according to the se-
verity of hemophilia in the family is nearly the same äs
the distribution according to the severity found in the
population of hemophiliacs who formed the basis of the
survey population. Two thirds of the women were famil-
iär with hemophilia because they had a close relative (a
father, a brother, or a son) with hemophilia. The others
had a further removed relative (an uncle, a cousin, or a
nephew) with hemophilia. More than half of the respon-
dents were married but less than half had children.
Carrier Testing and Knowledge
Forty-nine percent of the respondents had been tested
for carriership. Another 10% were not tested but were
informed by a physician about the heredity of hemo-
philia, and 41% had not been tested and were never
informed. However, more than 95% of the respondents
considered carrier testing useful.
Information about the heredity of hemophilia,
whether or not in combination with carrier testing, was
given in more than half of the cases by the hematologist
or pediatrician at the hemophilia center. One third were
TABLE I. General Characteristics of the Survey Population
(n =549)
^ %
Severity of hemophilia in the family,
Severe 40
Moderately severe 21
Mild 39
Family relation to nearest patient,
Mother 12
Sister 39
Daughter 14
Aunt 8
Niece 11
Cousin 17
Marital Status,
Unmarried 46
Married/divorced/widowed 54
Children,
Yes 41
No 59
informed by clinical geneticists and a small minority by
general practitioners.
The age at which women were tested for carriership
varied from 2 to 37 years and was 20 years on average.
Twenty-three percent were tested before age 15 years. A
relatively large group of these women, about 45%,
stated that, notwithstanding the carrier detection test,
they had not received information about the heredity of
hemophilia. Half of the women tested had been tested
more than 10 years before this survey.
The knowledge of the respondents about hemophilia,
the heredity of hemophilia, and the present facilities for
carrier testing and prenatal diagnosis was assessed for
women who had been tested and women who had not
been tested (Table II). The minimum scores for the scales
were zero, but we have to bear in mind that a score
halfway through the ränge could easily be obtained by a
respondent who knew nothing about the subject. Table
II shows small but statistically significant differences
between the two groups. Some misconceptions were
TABLE II. Knowledge About Hemophilia, the Heredity of
Hemophilia, and Carrier Testing and Prenatal Diagnosis
for Women Who Were Tested for Carriership and Women
Who Were Not Tested (One-Tailed Test)
Mean score T-Test
Knowledge of
Hemophilia
(ränge 0-8)
Heredity of
hemophilia
(ränge 0-8)
Present facilities
of carrier testing
and prenatal
diagnosis
(ränge 0-7)
Carrier
test
(n = 240)
6.3
6.6
6.0
No carrier
test
(n = 277)
5.4
6.1
5.6
T
7.7
4.3
3.5
P
<.0005
<.0005
<.0005
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found to be widespread, even among the women who had
been tested. Many warnen believed that:
• A small cut on a imger is dangerous for a hemo-
philiac.
• The severity of hemophilia within a family may
vary from one patient to another.
• The likelihood of carriership for a niece or cousin of a
hemophiliac is less than l in 100.
• The daughter of a hemophiliac is not necessarily a
carrier.
Factors Influencing the Use
of Carrier Detection Tests
Table III shows the association between carrier test-
ing and four independent variables. Married women,
women with children, and women related to patients
with severe hemophilia had been tested more often than
others. When the patient was a relative in the first
degree or the son of a sister, at least half of the women
had been tested. When the nearest patient was an uncle
or a cousin, only 27 and 19% had been tested, respec-
tively. Table III shows the Situation concerning marital
status, parenthood, and family relation at the time of
the study. It is possible that at the time of carrier testing,
some women were not yet married or had no children,
whereas their Situation has changed in the meantime.
Also, it is possible that the "nearest" patient was "more
distant'' and that a hemophilic son or nephew was born
afterwards. This means a slight overestimation of the
percentage who had carrier testing in the group of mar-
ried women and mothers and a slight underestimation
for the group of cousins and nieces and either is possible
for the group of aunts.
Half of the women were not tested for carriership.
Forty percent of them planned to be tested in the future,
35% thought they might have the test later, and 26% did
TABLE III. The Use of Carrier Detection Tests Associated
With Marital Status, Parenthood, Severity of Hemophilia,
and Family Relation to the Nearest Patient*
Carrier detection test
Marital Status
Unmarried
MarrieoVdivorced/widowed
Children
No children
Children
Severity of hemophilia
Severe
Moderately severe
Mild
Family relation to nearest patient
Mother
Sister
Daughter
Aunt
Niece
Cousin
Yes,
39
58
41
62
59
54
40
70
62
50
53
27
19
No,
61
42
59
38
41
46
60
30
38
50
47
73
81
Total
(n)
(255)
(293)
(323)
(222)
(211)
(113)
(203)
(64)
(210)
(74)
(43)
(62)
(93)
not intend to apply for testing. About a quarter ofthese
untested women stated that they had not known about
the possibility of carrier detection tests until they re-
ceived our questionnaire. Ignorance of the facilities for
carrier testing was associated with family relation to
the nearest patient: the "more distant" relatives were
less often acquainted with it (Table IV). The respondents
who were acquainted with the possibility of carrier de-
tection tests were asked to mark one or more reasons
why they had not been tested. The following reasons
were given most often:
• I intend to have the test, but I haven't got to it yet
(68).
• I will apply for testing when I am older (39).
• I will apply for testing when I start a family (16).
• I think that I am not a carrier (18).
• I am an obligate carrier (16).
• I do not know where I can have a carrier detection
test (15).
It appeared that for 18 women the reason for not
having a carrier detection test was the conviction that
they were not a carrier. For others the idea that carrier-
ship was unlikely could have been a factor. Table V
shows the assessments of the probability of carriership
made by the women who had not been tested. About 40%
of this group did not give an estimation of their proba-
bility of carriership in percentages. If they did, it ap-
peared that they often under- or overestimated their
prior probability of being a carrier. For instance about
40% of the daughters of hemophiliacs in this group did
not know that they were obligate carriers and almost
40% of the untested cousins estimated their probability
of being a carrier to be less than 5% or even less than 1%.
Prenatal Diagnosis
The women who had no experience with prenatal di-
agnosis for hemophilia were asked their opinion on ter-
mination of pregnancy because of hemophilia. Half of
the women were found to be opposed to abortion. When
hemophilia in the family was more severe, fewer women
were opposed to abortion (Table VI). We also analysed
whether or not there was an association between the
attitude toward abortion and the probability of being a
carrier. The analysis was restricted to women tested for
carriership; they were divided into three categories:
probably/sure a carrier, perhaps a carrier, and probably/
TABLE IV. Ignorance of the Possibility of Carrier Testing
*The family relation is the relation at the time of the study.
Family rela-
tion to nearest
patient
Mother
Sister
Daughter
Aunt
Niece
Cousin
Total
Ignorance
Yes,
%
6
6
12
14
19
30
13
of carrier
No,
%
94
94
88
86
81
70
87
testing
Total
(n)
(64)
(210)
(74)
(43)
(62)
(92)
(545)
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TABLE V. Estimation of the Probability of Carriership by the Untested Women
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Estimation of probability of carriership
Too low
Correct
Too high
No percentage/do not know
Mother
(n =19)
5
63
32
Family
Sister
(n = 80)
14
28
9
50
relation to nearest patient, %
Daughter
(n = 37)
35
54
11
Aunt
(n = 20)
25
20
15
40
Niece
(n = 45)
9
16
26
49
Cousin
<n = 75)
38
11
6
44
TABLE VI. Attitüde Toward Termination of Pregnancy
Because of Hemophilia and Severity of Hemophilia*
Severity of hemophilia, %
Attitüde
Not opposed
No opinion
Opposed
* χ
2
 = 10.8, df
Severe
(n = 184)
38
20
42
= 4, P = .03,
Moderate
(n = 103)
30
20
51
Cramer's V
Mild
(n = 191)
25
16
59
= .10.
Total
(n = 495)
31 '
19
51
sure not a carrier. It turned out that there was no such
association between the attitude toward termination of
pregnancy and the probability of being a carrier among
the women tested for carriership (χ2 = 2.2, P = .70).
However, äs a group the tested women were less often
opposed to abortion than the not-tested women: 417c v.
58% was opposed (χζ = 21.8, df = 2,P< .0001, Cramer's
V = .21).
We also asked all the women whether or not they
thought termination of pregnancy was acceptable in
various circumstances, including hemophilia. As has
been explained in the section on Methode these circum-
stances form a strong hierarchical scale. Table VII shows
the hierarchy of these circumstances. Hemophilia äs a
reason for abortion appeared to be hardly more accept-
able than an abortion on social grounds. This corrobo-
rates the fmdings of Table VI.
In addition to the large group of women who opposed
termination of pregnancy because of hemophilia, it ap-
peared that a minority had no clear opinion (Table VI) or
was unsure (Table VII).
Only 24 respondents, l l<7c of the women with children,
had undergone prenatal diagnosis. All the women were
asked whether or not they would make use of prenatal
diagnosis in the future if it meant that they might have
to undergo an abortion in the 8-10th week or the
18-20th week of pregnancy. The only possible answers
were yes and no. Fifteen percent answered yes if prena-
tal diagnosis and termination could only take place in
the 18-20th gestational week, while 31% answered yes
to prenatal diagnosis and termination in the 8-10th
week.
The following reasons for not making use of prenatal
diagnosis in the past or not intending to do so in the
future scored high (more than one answer could be men-
tioned):
• I accept the possibility that the child will have he-
mophilia (184).
• The hemophilia in my family is not serious enough
for that (108).
• I think the risk of having a hemophilic child is
rather small (103).
• I am against abortion (97).
• I can't bear the thought of having an abortion after I
have feit that the baby is living (72).
• I did not know that prenatal diagnosis was possible
(61).
• I am afraid for injury to the baby because of the
examination (29).
• I am afraid of having a miscarriage caused by the
examination (26).
The Relation Between Carrier Detection Tests,
Prenatal Diagnosis, and Reproductive Behaviour
Almost all the respondents agreed that carrier testing
is useful. Nevertheless, only a minority would opt for
prenatal diagnosis. This raises the question äs to the
consequences of carrier testing for reproductive choices.
In Table VIII the survey population is broken down into
TABLE VII. Attitude Towards Abortion in Different Circumstances
I think abortion is acceptable if: Agreed Unsure Disagreed
My health is in danger because of the pregnancy 80 14 6
The health of the baby is in danger because of the preg- 72 20 8
nancy
Prenatal diagnosis shows a serious disease 57 34 9
Prenatal diagnosis shows Down syndrome 46 31 23
Prenatal diagnosis shows hemophilia 22 25 53
The baby is unwanted (for other than medical reasons) 21 24 56
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TABLE VIII. Cross-tabulation of Attitüde Towards Prenatal
Diagnosis and Reproductive Behavior (n = 312)
The No. of children
will be/has been
restricted because of
hemophilia
Attitüde towards prenatal diagnosis
and potential abortion, n
Acceptance No acceptance Total
Yes/possibly
No
Total
75
47
122
61
129
190
136
176
312
*Excluded from this analysis are: the mothers of a hemophilic son, the
untested women who do not intend to be tested in the future, and the
women who have been tested and are probably not a camer or have a
probability of carriership lower than 26%.
a group ofthose who stated that hemophilia will (possi-
bly) implicate a restriction in the number of children
born in the future, or already has resulted in restriction
in the number of children, and a group of those who
stated that hemophilia did or does not have these impli-
cations. In addition, the survey population is broken
down into a group with an accepting attitude toward
prenatal diagnosis and a group ofthose who do not have
an accepting attitude toward it. Tested respondents with
a low probability of carriership were excluded, because
we assumed that the reproductive behaviour of many of
them would be influenced by the assumption that they
were not a carrier. Also, mothers of a hemophilic son
were excluded because we feit that they might restrict
the number of children, not out of fear of having another
hemophilic child, but because the first one needed extra
care. Women who were not intending to have a carrier
test in the future were excluded äs well.
Less than half of the women (136/312) stated that they
(possibly) would restrict or had restricted the number of
children because of hemophilia; the others stated that
the number of children was not or would not be re-
stricted because of hemophilia. It appeared that 183
women feit that hemophilia might have consequences
on their reproductive behavior: they would make use of
prenatal diagnosis and, if necessary, have an abortion,
or they would (possibly) restrict the number of children.
For 129 women (41%), the grounds for undergoing a
carrier detection test did not necessarily lie in the pre-
vention of the birth of a hemophilic son.
DISCUSSION
Figures on counseling at the clinical genetics centers
in The Netherlands suggest that many prospective par-
ents who are eligible for genetic counseling do not make
use of these genetic counseling facilities [Ter Haar and
Niermeijer, 1982; Frets et al., 1988].
This study gives an overview of the experiences of and
attitudes toward carrier testing and prenatal diagnosis
among 549 potential and obligate carriers of hemophilia
in The Netherlands. We estimate we have covered
roughly one quarter of the possible and obligate carriers
in The Netherlands.
Hemophiliacs are less likely to have given us the
addresses of female relatives they rarely meet and, on
the whole, female relatives who do not keep in touch
with the patient will be less well-informed about the
heredity of hemophilia, carrier testing, and prenatal
diagnosis. This means that the results of our study will
overestimate the use of carrier testing and knowledge
about the heredity of hemophilia and the possibility of
carrier testing and prenatal diagnosis. With this restric-
tion in mind we think that, given the high response rate,
we can give a reliable overview of carrier testing and
prenatal diagnosis for hemophilia in The Netherlands.
Seven out of eight potential and obligate carriers were
acquainted with carrier testing. The majority of the
group who had been tested for carriership had not yet
had an affected child. This reflects a general trend in
genetic counseling: parents of affected children used to
be the largest group of clients for genetic advice in the
past but presently they are outnumbered by prospective
parents with affected relatives [Ter Haar and Niermei-
jer, 1982].
Half of the potential carriers had not (yet) been tested.
Most of these women argued that they considered being
tested but had not come to it yet, or that they intended to
be tested later on when they would Start a family. This
. corresponds with the higher percentage of tested women
among those who were married or who had children.
However, whether or not carrier testing has been carried
out appears also strongly associated with the family
relation to the nearest patient. This suggests also other
causal factors. One factor is the ignorance of the possi-
bility of carrier testing, which is higher among the
"more distant" relatives. Given the widespread miscon-
ception we found in our survey that cousins and nieces
have a chance of less than lc/c of being a carrier, an
additional explanation appears to be that cousins and
nieces are less well-informed about the heredity of he-
mophilia. Furthermore, cousins and nieces, not being
part of the nuclear family of the hemophiliac, often are
socially and psychologically less involved with the pa-
tient and the problems of the disease, which may add to
this lack of Information in these more distant relatives.
As a result they may feel themselves less inclined to be
tested. These factors make the Statements of most of the
respondents about future testing somewhat unreliable:
if a woman intends to undergo testing in the future, but
thinks at the same time that she is not a carrier, then
tomorrow never comes.
Eleven percent of the respondents with children made
use of prenatal diagnosis. This rather low percentage
can partly be explained by the limited availability of
adequate techniques at that time. A few years ago cho-
rionic villus biopsy and DNA analysis were introduced
which offered the advantage of prenatal diagnosis ear-
lier in pregnancy. About 30% of our respondents stated
that they will apply for prenatal diagnosis and potential
abortion in the future if this is done early in pregnancy.
This is twice the number of women that will apply for
this technique if it is only possible in the 18-20th gesta-
tional week. Lubs and Falk [1977] also found a redoub-
ling of the number of persons who opted for prenatal
diagnosis for hemophilia when diagnostic techniques
improved: only 14% opted for an abortion when prenatal
diagnosis was restricted to sex determination; 27%
opted for an abortion when prenatal diagnosis also in-
cluded fetal blood sampling, which implied that only
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hemophilic boys would be aborted [Lubs and Falk,
1977].
However, for the majority of female relatives, prenatal
diagnosis and potential termination of pregnancy still
do not form an Option. This corroborates the findings of
Lubs and Falk [1977], Francis and Kasper [1983], and
Kraus and Brettler [1988] in the United States and the
findings of Markova et al. [1984] in Scotland and Can-
ada. Evans and Shaw [1979] found a slightly higher
acceptance in the United Kingdom, but still half of the
respondents were opposed to prenatal diagnosis, notably
because of the late time of abortion. Barrow et al. [1982]
and Miller et al. [1987] found a higher acceptance in the
United States than the studies mentioned before but
their survey populations consisted largely of women
seen at the hemophilia center because they were preg-
nant, and this will have caused a bias toward a more
favorable attitude. Contrary to these findings, which
are restricted to Western Europe and the United States,
are the results of a Hungarian study on a group of
obligate carriers [Lajos and Czeisel, 1987]. Forty-seven
out of the 57 carriers favored prenatal diagnosis and 43
would have the pregnancy terminated in the case of a
male fetus.
However, attitudes toward prenatal diagnosis are not
only determined by the possibility of diagnostic tech-
niques but also by the perceived bürden of the disease.
Since the introduction of modern Substitution therapy
for hemophilia, hemorrhages have fewer consequences
and this is reflected in improvements in the medical and
social Situation of patients [Smit et al., 1989]. The result
is that many prospective parents nowadays class hemo-
philia among the less serious diseases for which an abor-
tion is not justified or for which the emotional, psycho-
logical, and physical consequences of an abortion are too
profound. Thus, modern hemophilia treatment renders
the disease less serious, äs a result of which fewer par-
ents feel obliged to prevent the birth of a hemophiliac.
At the same time, for those parents who wish to prevent
the birth of an affected child diagnostic procedures have
been improved. At first sight this would appear to mean
fewer problems for fewer people. Nevertheless a consid-
erable group of (prospective) parents do not have a clear
opimon on termination of pregnancy because of hemo-
philia. Maybe they have never considered the problem,
but it is more likely that conflicting values make it
difficult for them to form a clear opinion. The less serious
nature of hemophilia combined with improved prenatal
diagnosis techniques may leave the same group of pro-
spective parents in doubt.
It has been pointed out that, given the increasing
possibilities for diagnosis of genetic diseases and the
great amount of publicity they receive, people feel
obliged to make use of diagnostic procedures to preclude
feelings of uncertainty and regret [Tijmstra, 1987]. Pro-
viding Information about the heredity of a disease, car-
rier testing, and reproductive choices to prospective par-
ents means that these parents may feel themselves
obliged and, therefore, are forced to make a well-consid-
ered decision regarding their reproductive behavior,
contrary to prospective parents who are ignorant of he-
reditary diseases in their family. This need to make a
decision is often experienced äs a bürden, the more so
because one of the considerations is how others will view
the parents äs decision makers [Lippman-Hand and
Fräser, 1979]. Little is known about the influence of
perceived consequences, e.g., the influence of perceived
social reactions to parents' decisions regarding their
reproductive behavior. Certainly many clients will feel
that they have to justify their actions, or that they have
to be able to justify their actions afterwards. We may
conclude that the possibility of prenatal diagnosis con-
fronts parents with many puzzles in the short-term, but
with some reservation we may say that it leads to fewer
problems for some of them in the long-term.
In addition to this discussion on the value of prenatal
diagnosis we would like to comment on the value of
carrier testing. For some of the respondents, and proba-
bly for the financiers, the function of carrier testing lies
in the prevention of the birth of affected children. For
more than 40% of our respondents carrier testing does
not explicitly have this function: they do not intend to
make use of prenatal diagnosis; neither will they re-
strict the number of offspring. Moreover few respon-
dents feel that carrier testing is useless. This gives rise
to the question of what the function of carrier testing is
for the latter group. Perhaps many people feel obliged,
äs has been discussed before, to make use of diagnostic
procedures, at least when these do not yet have repro-
ductive implications. Opinions about the usefulness of
carrier testing may be for this group a rather automatic
consequence of a generally optimistic view on new medi-
cal diagnostic techniques, instead of a well-considered
opinion. However, for others a major function of carrier
testing is that, being part of the procedure of genetic
counseling, it supplies Information about risk rates and
aspects of the hereditary disease. This offers potential
carriers the possibility of familianzing themselves with
their Situation and it answers the question of whether or
not they should Start the difficult process of decision
making regarding their reproductive behavior in the
case of carriership. Furthermore, Information dispels
misconceptions and unjustified anxiety. Many women
with a family history of mild hemophilia, for instance,
are relieved to hear that they cannot be carriers of severe
hemophilia. From our results it appears that women at
risk are not optimally informed and that decisions con-
cerning family planning and use of prenatal diagnosis
are sometimes reached with difficulty. In giving Infor-
mation and helping prospective parents to come to a
decision regarding reproduction lies the usefulness of
genetic counseling centers.
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